If you suspect you're experiencing side effects from your medication, report them through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
The most commonly reported concerns include inadequate protein intake, lean mass loss, vitamin D deficiency, thiamine and other B-vitamin issues, iron depletion, anemia, and low calcium, magnesium, and potassium intake
Tirzepatide 15mg 15mg Tirzepatide is a dual GIP/GLP-1 receptor agonist that has set new benchmarks in metabolic and weight loss research
Banned by WADA since 2009 after mouse studies showed 44% endurance gains
The FDA approved a 2.4mg weekly dose of semaglutide, but you start at a much lower dose and gradually build up over months